CCI
ORMP icon

Columbus Circle Investors’s Oramed Pharmaceuticals ORMP Stock Holding History

Columbus Circle Investors’s Portfolio ORMP Stock Details ORMP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q2 		– Sell
-44,725
Closed -$528K – 295
2014
Q1 		$528K Buy
+44,725
New +$755K ﹤0.01% 276

Other funds holding ORMP

AWMDMG
Austin W. Marxe & David M. Greenhouse New York $733M AUM 21.72% 1-Year Est. Return
Stifel Financial
Stifel Financial St. Louis, Missouri $109B AUM 21.36% 1-Year Est. Return
GIM
Greylin Investment Management Orange, Virginia $598M AUM 18.59% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
CA
Commerzbank Aktiengesellschaft Frankfurt, Germany $4.78B AUM 25.31% 1-Year Est. Return
HSBC Holdings
HSBC Holdings London, United Kingdom $192B AUM 27.2% 1-Year Est. Return
TAM
Tocqueville Asset Management New York $6.74B AUM 32.29% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
U
UBS Zurich, Switzerland $136B AUM 16.36% 1-Year Est. Return

Columbus Circle Investors's ORMP Position: Q2 2014 in Review

Columbus Circle Investors sold out of Oramed Pharmaceuticals (ORMP) in Q2 2014, closing a stake of 44,725 shares — an estimated $528K sold.

Columbus Circle Investors first reported a position in ORMP in Q1 2014 and held it in 1 quarter. The position peaked at $528K in Q1 2014. 22 funds tracked by Wall St. Rank hold ORMP as of Q2 2014.

  • Columbus Circle Investors reported no remaining Oramed Pharmaceuticals position as of Q2 2014 after selling out during the quarter.
  • Columbus Circle Investors sold 44,725 Oramed Pharmaceuticals shares in Q2 2014, an estimated $528K.
  • Columbus Circle Investors first reported a position in Oramed Pharmaceuticals in Q1 2014 and held it in 1 quarter.
  • Columbus Circle Investors's Oramed Pharmaceuticals position peaked at $528K in Q1 2014.
  • 22 funds tracked by Wall St. Rank held Oramed Pharmaceuticals as of Q2 2014.

Based on Columbus Circle Investors's 13F filing for Q2 2014, filed 31 Jul 2014.